Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor

Jian Zhou, Gina Hernandez, Szu Wei Tu, Jessica Scholes, Hong Chen, Ching Ping Tseng, Jer Tsong Hsieh

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The down-regulation of DOC-2/DAB2 gene, which encodes a unique phosphoprotein modulating signal pathways elicited by exogenous stimuli, is often associated with several cancer types; however, the underlying mechanism is still unknown. Dramatically different expression levels of DOC-2/DAB2 mRNA and protein are observed among several human transitional cell carcinoma (TCC) cell lines, suggesting that transcriptional regulation may play a role in these cells. In this study, we have shown that the histone acetylation status associated with the 5′ upstream regulatory sequence of DOC-2/DAB2 gene is one of the key determinants for its gene expression. In addition, GATA6 but not other GATA family members, such as GATA2 and GATA4, can specifically induce DOC-2/DAB2 promoter activity, although GATA transcription factors share a very similar DNA-binding sequence. We also show that increased histone acetylation and the presence of GATA6 have a synergistic effect on DOC-2/DAB2 promoter activity, which results in the elevation of DOC-2/DAB2 protein expression. Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., GATA6), which underlie the reduced DOC-2/DAB2 protein expression in TCC cells.

Original languageEnglish (US)
Pages (from-to)6089-6096
Number of pages8
JournalCancer Research
Volume65
Issue number14
DOIs
StatePublished - Jul 15 2005

Fingerprint

Histone Deacetylase Inhibitors
Transitional Cell Carcinoma
Acetylation
Histones
Gene Expression
GATA6 Transcription Factor
GATA Transcription Factors
Genes
Proteins
Phosphoproteins
Signal Transduction
Down-Regulation
Cell Line
Messenger RNA
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor. / Zhou, Jian; Hernandez, Gina; Tu, Szu Wei; Scholes, Jessica; Chen, Hong; Tseng, Ching Ping; Hsieh, Jer Tsong.

In: Cancer Research, Vol. 65, No. 14, 15.07.2005, p. 6089-6096.

Research output: Contribution to journalArticle

Zhou, Jian ; Hernandez, Gina ; Tu, Szu Wei ; Scholes, Jessica ; Chen, Hong ; Tseng, Ching Ping ; Hsieh, Jer Tsong. / Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor. In: Cancer Research. 2005 ; Vol. 65, No. 14. pp. 6089-6096.
@article{95d1319027104f6985f13743686c5deb,
title = "Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor",
abstract = "The down-regulation of DOC-2/DAB2 gene, which encodes a unique phosphoprotein modulating signal pathways elicited by exogenous stimuli, is often associated with several cancer types; however, the underlying mechanism is still unknown. Dramatically different expression levels of DOC-2/DAB2 mRNA and protein are observed among several human transitional cell carcinoma (TCC) cell lines, suggesting that transcriptional regulation may play a role in these cells. In this study, we have shown that the histone acetylation status associated with the 5′ upstream regulatory sequence of DOC-2/DAB2 gene is one of the key determinants for its gene expression. In addition, GATA6 but not other GATA family members, such as GATA2 and GATA4, can specifically induce DOC-2/DAB2 promoter activity, although GATA transcription factors share a very similar DNA-binding sequence. We also show that increased histone acetylation and the presence of GATA6 have a synergistic effect on DOC-2/DAB2 promoter activity, which results in the elevation of DOC-2/DAB2 protein expression. Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., GATA6), which underlie the reduced DOC-2/DAB2 protein expression in TCC cells.",
author = "Jian Zhou and Gina Hernandez and Tu, {Szu Wei} and Jessica Scholes and Hong Chen and Tseng, {Ching Ping} and Hsieh, {Jer Tsong}",
year = "2005",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-04-3672",
language = "English (US)",
volume = "65",
pages = "6089--6096",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor

AU - Zhou, Jian

AU - Hernandez, Gina

AU - Tu, Szu Wei

AU - Scholes, Jessica

AU - Chen, Hong

AU - Tseng, Ching Ping

AU - Hsieh, Jer Tsong

PY - 2005/7/15

Y1 - 2005/7/15

N2 - The down-regulation of DOC-2/DAB2 gene, which encodes a unique phosphoprotein modulating signal pathways elicited by exogenous stimuli, is often associated with several cancer types; however, the underlying mechanism is still unknown. Dramatically different expression levels of DOC-2/DAB2 mRNA and protein are observed among several human transitional cell carcinoma (TCC) cell lines, suggesting that transcriptional regulation may play a role in these cells. In this study, we have shown that the histone acetylation status associated with the 5′ upstream regulatory sequence of DOC-2/DAB2 gene is one of the key determinants for its gene expression. In addition, GATA6 but not other GATA family members, such as GATA2 and GATA4, can specifically induce DOC-2/DAB2 promoter activity, although GATA transcription factors share a very similar DNA-binding sequence. We also show that increased histone acetylation and the presence of GATA6 have a synergistic effect on DOC-2/DAB2 promoter activity, which results in the elevation of DOC-2/DAB2 protein expression. Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., GATA6), which underlie the reduced DOC-2/DAB2 protein expression in TCC cells.

AB - The down-regulation of DOC-2/DAB2 gene, which encodes a unique phosphoprotein modulating signal pathways elicited by exogenous stimuli, is often associated with several cancer types; however, the underlying mechanism is still unknown. Dramatically different expression levels of DOC-2/DAB2 mRNA and protein are observed among several human transitional cell carcinoma (TCC) cell lines, suggesting that transcriptional regulation may play a role in these cells. In this study, we have shown that the histone acetylation status associated with the 5′ upstream regulatory sequence of DOC-2/DAB2 gene is one of the key determinants for its gene expression. In addition, GATA6 but not other GATA family members, such as GATA2 and GATA4, can specifically induce DOC-2/DAB2 promoter activity, although GATA transcription factors share a very similar DNA-binding sequence. We also show that increased histone acetylation and the presence of GATA6 have a synergistic effect on DOC-2/DAB2 promoter activity, which results in the elevation of DOC-2/DAB2 protein expression. Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., GATA6), which underlie the reduced DOC-2/DAB2 protein expression in TCC cells.

UR - http://www.scopus.com/inward/record.url?scp=22244445831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244445831&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3672

DO - 10.1158/0008-5472.CAN-04-3672

M3 - Article

C2 - 16024609

AN - SCOPUS:22244445831

VL - 65

SP - 6089

EP - 6096

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 14

ER -